Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by KayDayon Dec 08, 2010 9:23pm
665 Views
Post# 17821555

Numoda

NumodaSince Stockguy mentioned it, I find it odd that no one has looked into Numoda. Read this link and tell me it doesn't fit. From what I understand this company doesn't look at a biotech unless it has legs and can succeed. For those who were on the call this is their description of the interested company verbatim. If these guys manage the phase III trials we are guaranteed success. There is no promise that a deal was made or that this is the company but... it fits. Look forward to your thoughts.
https://www.numodacapital.com/investment_strategy.html
Bullboard Posts